What women are eligible for 17P treatment to reduce the risk of preterm birth recurrence?
Women who are pregnant with a singleton pregnancy and who have a history of a previous singleton spontaneous preterm birth between 200 and 366 weeks gestation are eligible. Currently, the North Carolina 17P Project is making this medication available free of charge to eligible mothers who have Medicaid, are uninsured, or whose private insurer does not reimburse for the medication.
